BP000027-CYT-496: Recombinant Human Vascular Endothelial Growth Factor (VEGF) Protein, His Tag
Source: E. coli-derived.
Purity: > 90% by SDS-PAGE.BP000027-CYT-574: Recombinant Mouse VEGF (121 a.a) Protein
Source: E. coli-derived.
Purity: > 97% by SDS-PAGE and RP-HPLC.BP001214-PRO-679: Recombinant Human Annexin A1 (ANXA1) Protein
Source: E. coli-derived.
Purity: > 90.0% by SDS-PAGE.BP001122-PRO-326: Recombinant Human Small ubiquitin-related modifier 1 (SUMO1) protein
Source: E. coli-derived.
Purity: > 98.0% by RP-HPLC and SDS-PAGE.BP001122-PRO-980: Recombinant Human Small ubiquitin-related modifier 1 (SUMO1) protein, His Tag
Source: E. coli-derived.
Purity: > 90% by SDS-PAGE.BP001307-PRO-1178: Recombinant Human Nucleolar protein 3 (NOL3)
Source: E. coli-derived.
Purity: >90.0% as determined by SDS-PAGE.BP001338-PRO-431: Recombinant Human Leukocyte-Associated Immunoglobulin-Like Receptor 1 (LAIR1) Protein
Source: Escherichia Coli-derived.
Purity: > 95% by SEC-HPLC and SDS-PAGE.BP001353-PRO-923: Recombinant Human Oxidized Low-Density Lipoprotein Receptor 1 (OLR1) Protein
Source: E. coli-derived.
Purity: >90.0% as determined by SDS-PAGE.BP001239-PRO-768: Recombinant Human Bcl-2-like protein 2 (BCL2L2)
Source: E. coli-derived.
Purity: > 95.0% by SDS-PAGE.BP000027-CYT-260: Recombinant Human Vascular Endothelial Growth Factor (VEGF) Protein, CHO
Source: Chinese Hamster Ovarian Cell-derived.
Determined by its ability to stimulate 3H-Thymidine incorporation in human ublical vein endothelial cells, the ED50 for this effect was found to be 2-6 ng/ml corresponding to a Specific Activity of 166,667-500,000 IU/mg.
Purity: > 97% by SDS-PAGE and RP-HPLC.